Scarica l'app Stockscreener
129.50
1.42%
1.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DVA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$127.69
Aprire:
$128.33
Volume 24 ore:
949.57K
Relative Volume:
1.11
Capitalizzazione di mercato:
$9.78B
Reddito:
$12.82B
Utile/perdita netta:
$936.34M
Rapporto P/E:
12.06
EPS:
10.74
Flusso di cassa netto:
$1.47B
1 W Prestazione:
-6.48%
1M Prestazione:
-9.94%
6M Prestazione:
-25.39%
1 anno Prestazione:
-6.75%
Intervallo 1D:
$127.32
$130.51
Intervallo di 1 settimana:
$126.07
$141.52
Portata 52W:
$126.07
$179.60
Davita Inc Stock (DVA) Company Profile
Nome
Davita Inc
Settore
Industria
Telefono
310-536-2668
Indirizzo
2000 16TH STREET, DENVER, CO
Confronta DVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
129.50 | 9.14B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
381.61 | 85.68B | 72.70B | 5.97B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
165.58 | 14.07B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.07 | 13.80B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
117.58 | 11.75B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
172.30 | 10.53B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2023-08-07 | Aggiornamento | UBS | Neutral → Buy |
| 2022-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Downgrade | UBS | Buy → Neutral |
| 2022-08-19 | Ripresa | UBS | Buy |
| 2022-06-21 | Reiterato | BofA Securities | Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2018-12-14 | Iniziato | Barclays | Overweight |
| 2018-11-28 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Iniziato | UBS | Sell |
| 2018-11-08 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2017-12-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2016-12-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Davita Inc Borsa (DVA) Ultime notizie
Can DaVita’s (DVA) Share Buybacks Offset Mixed Q2 Earnings Trends? - simplywall.st
DaVita Inc. (NYSE:DVA) Q2 2025 Earnings Call Transcript - MSN
Barclays Updates DaVita (DVA) with Lower Price Target to $160 | - GuruFocus
DaVita Healthcare’s Resilient Earnings Call Amid Challenges - TipRanks
DaVita Shares Plunge 9% Amid 150% Volume Surge to $430M, Rank 264th in Market Activity - AInvest
DaVita 2025 Q2 Earnings Net Income Falls 8.2% Despite Revenue Growth - AInvest
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands - The Globe and Mail
DaVita Inc. Stock Dives 8.5% on Declining Treatment Volumes and Forecast CutNews and Statistics - IndexBox
Why DaVita (DVA) Stock Is Nosediving - Yahoo Finance
Huge healthcare breach sees nearly a million patients hit following DaVita ransomware attackmake sure you're safe - TechRadar
Barclays Adjusts DaVita Price Target to $160 From $169 - MarketScreener
DaVita stock hits 52-week low at $131.09 amid market fluctuations - Investing.com Nigeria
Over 900K hit by DaVita ransomware hack - SC Media
DaVita 2025 Q2 Earnings Mixed Performance as Net Income Falls 8.2% - AInvest
Deutsche Bank Adjusts DaVita Price Target to $137 From $165, Maintains Hold Rating - MarketScreener
DaVita Inc. Exceeds Expectations with Strong Q2 2025 Revenue GrowthNews and Statistics - IndexBox
DaVita reiterates $2.01B–$2.16B adjusted operating income guidance for 2025 as cost controls offset volume headwinds - MSN
DaVita HealthCare: Q2 Earnings Snapshot - Greenwich Time
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Resilience and ... - uk.finance.yahoo.com
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Ch - GuruFocus
DaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Resilience and ... By GuruFocus - Investing.com Canada
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. (DVA): Mastering Capital Allocation in a High-Margin Dialysis Industry - AInvest
Strategic Cost Management as the Cornerstone of DaVita's Resilient Operational Performance in 2025 - AInvest
Can DaVita's Pattern of Revenue Outperformance Shape Its Broader Growth Narrative? (DVA) - simplywall.st
DaVita Outpaces Expectations Despite Cyberattack And Hurricane Setbacks - Finimize
Earnings call transcript: DaVita Q2 2025 beats estimates, stock dips - Investing.com
DaVita Inc reports results for the quarter ended June 30Earnings Summary - TradingView
DaVita’s (NYSE:DVA) Q2 Sales Beat Estimates - TradingView
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
DAVITA INC. SEC 10-Q Report - TradingView
DaVita beats quarterly profit on steady demand for dialysis services - TradingView
DaVita HealthCare Reports Strong Q2 Earnings, Surpassing ExpectationsNews and Statistics - IndexBox
DaVita Inc Q2 2025 Earnings: Revenue Surpasses Estimates at $3.3 - GuruFocus
DaVita Inc. Q2 Sales Increase - Nasdaq
DaVita earnings beat by $0.17, revenue topped estimates By Investing.com - Investing.com South Africa
DaVita earnings beat by $0.17, revenue topped estimates - Investing.com Australia
DaVita Inc Q2 2025 Earnings: Revenue Surpasses Estimates at $3.38 Billion, Adjusted EPS Beats at $2.95 - GuruFocus
DaVita Inc. 2nd Quarter 2025 Results - PR Newswire
Berkshire Hathaway buys $106.5M in Sirius XM, cuts $230M in DaVita - MSN
Dialysis company DaVita says more than 900,000 people affected by April ransomware attack - The Record from Recorded Future News
Investors Aren't Entirely Convinced By DaVita Inc.'s (NYSE:DVA) Earnings - simplywall.st
Berkshire Hathaway Boosts Sirius XM Stake to 37%, Sells DaVita Shares - WebProNews
Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings - inkl
Berkshire Hathaway Buys More Sirius XM Stock, Sells DaVita Shares in Recent Days - Barron's
Berkshire Hathaway buys $106.5M in Sirius XM, cuts $230M in DaVita (SIRI:NASDAQ) - Seeking Alpha
Insider Transactions Reported | DaVita(DVA)saw insider trading activity on 8/4/2025 - AInvest
Akebia Initiates Vafseo® (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization - Stock Titan
DaVita (DVA) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Is DaVita Inc. stock overvalued or undervaluedMaximize returns with strategic trading plans - Jammu Links News
Davita Inc Azioni (DVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):